Two Dimensional (2D) Silicon Transducer-Compression Plates for Breast Ultrasound

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT00859261
Collaborator
National Institutes of Health (NIH) (NIH), National Cancer Institute (NCI) (NIH)
21
1
1
71.1
0.3

Study Details

Study Description

Brief Summary

The study purpose is to help in the developement of 3 dimensional breast ultrasound imaging.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Experimental 3D Breast Ultrasound imaging
  • Procedure: Experimental Photoacoustic Imaging
N/A

Detailed Description

To assist in the developement of 3 dimensional breast ultrasound imaging and when possible compare the ultrasound results with 3D mammography (digital tomosynthesis mammography)or clinical mammography and ultrasound. Hopefully that this new, 3D ultrasound imaging can provide important information not found on mammograms or routine breast ultrasound.

Study Design

Study Type:
Interventional
Actual Enrollment :
21 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
2D Silicon Transducer-Compression Plates for Breast Ultrasound
Study Start Date :
Mar 1, 2009
Actual Primary Completion Date :
Feb 1, 2015
Actual Study Completion Date :
Feb 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Breast imaging using Ultrasound and Photoacoustic

Evaluating 3D ultrasound for breast abnormalities/masses/cysts. This includes ultrasound imaging and possibly photoacoustic imaging.

Procedure: Experimental 3D Breast Ultrasound imaging
Subjects will be seated and have the indicated breast positioned in the 3D breast ultrasound imaging device. An ultrasound gel will be applied to the breast by the technician. The breast will be gently compressed between the ultrasound plates to facilitate the 3D (dimensional)breast imaging. This imaging session will take approximately 30 minutes to complete.

Procedure: Experimental Photoacoustic Imaging
Subjects will be placed in a seated position for the photoacoustic tomography(PAT) imaging. The subjects will be given a laser protective mask to wear. Each subject will be instructed how to wear this mask(goggles) to protect their eyes during the imaging session. Pulse monitor leads may be placed on their chest to allow the computer to record the images of blood flow in the breast. The breast will be placed on the laser device platform and positioned so that the laser beam is appropriately directed to the targeted area of the breast. During the imaging the temperature of the skin under laser light, will be checked often with a thermometer to make sure that the skin is not getting too hot. This laser based imaging scan will take approximately 10 minutes to complete.
Other Names:
  • Photoacoustic Tomography (PAT)
  • Outcome Measures

    Primary Outcome Measures

    1. To prove the significance/capability of 3D Ultrasound imaging in comparison to current mammographic imaging. [1 year]

      Assess the quality of 3 D ultrasound in comparison to conventional mammography

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    30 Years to 80 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Healthy women OR

    • Women with suspected benign masses who may/or may not be going to biopsy

    • Women with cysts where no biopsy is recommended

    Exclusion Criteria:
    • Women who are pregnant

    • Women with breast implants

    • Prisoners

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Michigan Ann Arbor Michigan United States 48109

    Sponsors and Collaborators

    • University of Michigan
    • National Institutes of Health (NIH)
    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: Paul Carson, Ph.D., University of Michigan Basic Science Division

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Paul L. Carson Ph.D, Principal Investigator ( Ph.D ), University of Michigan
    ClinicalTrials.gov Identifier:
    NCT00859261
    Other Study ID Numbers:
    • HUM 15464
    • 2R01CA091713
    • R01CA115267
    First Posted:
    Mar 11, 2009
    Last Update Posted:
    May 5, 2016
    Last Verified:
    May 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 5, 2016